Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Selectis Health (GBCS) Accumulated Depreciation & Amortization (2017 - 2025)

Selectis Health's Accumulated Depreciation & Amortization history spans 13 years, with the latest figure at $15.9 million for Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 10.02% year-over-year to $15.9 million; the TTM value through Sep 2025 reached $15.9 million, up 10.02%, while the annual FY2024 figure was $14.9 million, 7.07% up from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2025 was $15.9 million at Selectis Health, up from $14.9 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $15.9 million in Q3 2025 and bottomed at $11.5 million in Q3 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $13.3 million (2022), against an average of $13.4 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization increased 17.19% in 2021 before it grew 0.77% in 2023.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $12.0 million in 2021, then increased by 14.97% to $13.8 million in 2022, then increased by 0.77% to $13.9 million in 2023, then rose by 7.07% to $14.9 million in 2024, then grew by 7.34% to $15.9 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Accumulated Depreciation & Amortization are $15.9 million (Q3 2025), $14.9 million (Q4 2024), and $14.5 million (Q3 2024).